Cheng X, Baki V, Moran M, Liu B, Yu J, Zhao M
Mol Metab. 2024; 86:101977.
PMID: 38936659
PMC: 11267048.
DOI: 10.1016/j.molmet.2024.101977.
Men S, Wang H
Drug Metab Dispos. 2022; 51(2):210-218.
PMID: 36351837
PMC: 9900862.
DOI: 10.1124/dmd.122.000859.
Negishi M, Kobayashi K, Sakuma T, Sueyoshi T
J Biol Chem. 2020; 295(45):15210-15225.
PMID: 32788213
PMC: 7650254.
DOI: 10.1074/jbc.REV120.007933.
Paszek M, Tukey R
Drug Metab Dispos. 2019; 48(1):25-30.
PMID: 31704714
PMC: 6904881.
DOI: 10.1124/dmd.119.089508.
de Haan L, van der Lely S, Warps A, Hofsink Q, Olthof P, de Keijzer M
J Clin Transl Res. 2019; 4(1):1-46.
PMID: 30761355
PMC: 6370335.
DOI: 10.18053/jctres.04.201801.001.
Teriflunomide Is an Indirect Human Constitutive Androstane Receptor (CAR) Activator Interacting With Epidermal Growth Factor (EGF) Signaling.
Carazo A, Dusek J, Holas O, Skoda J, Hyrsova L, Smutny T
Front Pharmacol. 2018; 9:993.
PMID: 30364229
PMC: 6193428.
DOI: 10.3389/fphar.2018.00993.
The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.
Mackowiak B, Hodge J, Stern S, Wang H
Drug Metab Dispos. 2018; 46(9):1361-1371.
PMID: 29759961
PMC: 6124513.
DOI: 10.1124/dmd.118.081042.
Interaction of the phosphorylated DNA-binding domain in nuclear receptor CAR with its ligand-binding domain regulates CAR activation.
Shizu R, Min J, Sobhany M, Pedersen L, Mutoh S, Negishi M
J Biol Chem. 2017; 293(1):333-344.
PMID: 29133527
PMC: 5766923.
DOI: 10.1074/jbc.M117.806604.
Multiple analyses indicate the specific association of NR1I3, C6 and TNN with low hip BMD risk.
Han Y, Zhao L, Lin Y, He H, Tian Q, Zhu W
J Genet Genomics. 2017; 44(6):327-330.
PMID: 28629900
PMC: 5822710.
DOI: 10.1016/j.jgg.2017.05.004.
Phenobarbital Meets Phosphorylation of Nuclear Receptors.
Negishi M
Drug Metab Dispos. 2017; 45(5):532-539.
PMID: 28356313
PMC: 5399647.
DOI: 10.1124/dmd.116.074872.
Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation.
Shizu R, Osabe M, Perera L, Moore R, Sueyoshi T, Negishi M
Mol Cell Biol. 2017; 37(10).
PMID: 28265001
PMC: 5477554.
DOI: 10.1128/MCB.00649-16.
Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation.
Hashiguchi T, Arakawa S, Takahashi S, Gonzalez F, Sueyoshi T, Negishi M
Mol Endocrinol. 2016; 30(10):1070-1080.
PMID: 27571290
PMC: 5045495.
DOI: 10.1210/me.2016-1105.
Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk.
Oladimeji P, Cui H, Zhang C, Chen T
Expert Opin Drug Metab Toxicol. 2016; 12(9):997-1010.
PMID: 27295009
PMC: 4992434.
DOI: 10.1080/17425255.2016.1201069.
p38 MAP Kinase Links CAR Activation and Inactivation in the Nucleus via Phosphorylation at Threonine 38.
Hori T, Moore R, Negishi M
Drug Metab Dispos. 2016; 44(6):871-6.
PMID: 27074912
PMC: 4885487.
DOI: 10.1124/dmd.116.070235.
Phenobarbital and Insulin Reciprocate Activation of the Nuclear Receptor Constitutive Androstane Receptor through the Insulin Receptor.
Yasujima T, Saito K, Moore R, Negishi M
J Pharmacol Exp Ther. 2016; 357(2):367-74.
PMID: 26994072
PMC: 4851327.
DOI: 10.1124/jpet.116.232140.
Nuclear receptors and nonalcoholic fatty liver disease.
Cave M, Clair H, Hardesty J, Falkner K, Feng W, Clark B
Biochim Biophys Acta. 2016; 1859(9):1083-1099.
PMID: 26962021
PMC: 5149456.
DOI: 10.1016/j.bbagrm.2016.03.002.
Mechanisms of xenobiotic receptor activation: Direct vs. indirect.
Mackowiak B, Wang H
Biochim Biophys Acta. 2016; 1859(9):1130-1140.
PMID: 26877237
PMC: 4975672.
DOI: 10.1016/j.bbagrm.2016.02.006.
The Use of the LanthaScreen TR-FRET CAR Coactivator Assay in the Characterization of Constitutive Androstane Receptor (CAR) Inverse Agonists.
Carazo A, Pavek P
Sensors (Basel). 2015; 15(4):9265-76.
PMID: 25905697
PMC: 4431184.
DOI: 10.3390/s150409265.
Deciphering the roles of the constitutive androstane receptor in energy metabolism.
Yan J, Chen B, Lu J, Xie W
Acta Pharmacol Sin. 2014; 36(1):62-70.
PMID: 25500869
PMC: 4571311.
DOI: 10.1038/aps.2014.102.
Effect of erythropoietin on hepatic cytochrome P450 expression and function in an adenine-fed rat model of chronic kidney disease.
Feere D, Velenosi T, Urquhart B
Br J Pharmacol. 2014; 172(1):201-13.
PMID: 25219905
PMC: 4280978.
DOI: 10.1111/bph.12932.